Recap: Reneo Pharmaceuticals Q3 Earnings

Reneo Pharmaceuticals (NASDAQ:RPHM) reported its Q3 earnings results on Monday, November 13, 2023 at 07:35 AM.

Here's what investors need to know about the announcement.

Reneo Pharmaceuticals reported in-line EPS of $-0.57 versus an estimate of $-0.57.

Revenue was down $0 from the same period last year.

Last quarter the company missed on EPS by $0.13 which was followed by a 4.31% drop in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Reneo Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

To add Benzinga News as your preferred source on Google, click here.

Reneo Pharmaceuticals (NASDAQ:RPHM) reported its Q3 earnings results on Monday, November 13, 2023 at 07:35 AM.

Here's what investors need to know about the announcement.

Reneo Pharmaceuticals reported in-line EPS of $-0.57 versus an estimate of $-0.57.

Revenue was down $0 from the same period last year.

Last quarter the company missed on EPS by $0.13 which was followed by a 4.31% drop in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Reneo Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

To add Benzinga News as your preferred source on Google, click here.